|
|
| Line 1: |
Line 1: |
| __NOTOC__
| | #REDIRECT [[Isradipine#Warnings]] |
| {{Isradipine}}
| |
| {{CMG}}; {{AE}} {{SS}}
| |
| | |
| ==Warnings and Precautions==
| |
| | |
| ===WARNINGS===
| |
| | |
| None
| |
| | |
| ===PRECAUTIONS===
| |
| | |
| ====General====
| |
| | |
| Blood Pressure: Because isradipine decreases peripheral resistance, like other [[calcium blockers]] isradipine may occasionally produce symptomatic [[hypotension]]. However, symptoms like [[syncope]] and severe [[dizziness]] have rarely been reported in hypertensive patients administered isradipine, particularly at the initial recommended doses (seeDOSAGE AND ADMINISTRATION).
| |
| | |
| Use in Patients with Congestive Heart Failure: Although acute hemodynamic studies in patients with [[congestive heart failure]] have shown that isradipine reduced afterload without impairing myocardial contractility, it has a negative inotropic effect at high doses in vitro and possibly in some patients. Caution should be exercised when using isradipine in congestive heart failure patients, particularly in combination with a beta-blocker.<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = ISRADIPINE CAPSULE [COBALT LABORATORIES] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=bf3425e0-428d-4bdb-ac9a-3b9d483df83a | publisher = | date = | accessdate = 28 February 2014 }}</ref>
| |
| | |
| ==References ==
| |
| {{Reflist|2}}
| |
| | |
| [[Category:Calcium channel blockers]]
| |
| [[Category:Dihydropyridines]]
| |
| [[Category:Benzoxadiazoles]]
| |
| [[Category:Carboxylate esters]]
| |
| [[Category:Cardiovascular Drugs]]
| |
| [[Category:Drugs]]
| |